Dear Sir, Autosomal dominant polycystic kidney disease (ADPKD) can be frequently complicated by chronic renal failure and hypertension [1]· In the literature there is little consensus on the pathogenesis of hypertension in patients with ADPKD. In fact, although it would seem obvious that the incidence of hypertension would increase as renal insufficiency becomes more severe, it has also been demonstrated that there is no correlation between the severity of hypertension and the severity of renal involvement, and that 15-20% of subjects with ADPKD without renal function impairment have hypertension and that blood pressure alterations can be found in ADPKD patients without renal function impairment before puberty [2] . Importantly, the genetic trait appears to be dominant. The main genie locus responsible for ADPKD is PKD-1, localized on the short arm of chromosome 16, which presents a 100% penetration [3] . However, another locus is involved in the disease. Called PKD-2, it is linked to chromosome 4, which is altered in 10% of patients, and modifications in it could give rise to an altered cellular membrane structure, and therefore to anomalous functioning of the ionic transport systems [4, 5] . Recently Vareesangthip et al. [6] identified altered Na/Li countertransport in ADPKD patients, and Rutherford et al. [7] found that patients with essential hypertension had an altered ionic transport system. However, this alteration is present in the erythrocytes of all ADPKD patients, and so it does not explain why hypertension develops in only 15-20% of such patients without renal function impairment. We therefore evaluated induced Ca2+/K+ flow in the erythrocytes of ADPKD subjects in order to ascertain whether ADPKD patients with hypertension but without renal function impairment also had alterations in other ionic transport systems. Our study was conducted on 40 subjects divided into four groups that were matched for age and gender as follows; 10 healthy controls (5 M, 5 F; mean age 52 ± 7 years); 10 with essential hypertension (5 M, 5 F; mean age 51 ± 8 years; mean systolic blood pressure 172 ± 15; mean diastolic blood pressure 105 ± 11); 10 normotensives with ADPKD (5 M, 5 F; mean age 48 ± 10 years); 10 with ADPKD and hypertension (5 M, 5 F; mean age 50 ± 6 years; mean systolic blood pressure 168 ± 23; mean diastolic blood pressure 103 ± 7). None of the hypertensive subjects was on diuretic or Ca antagonist therapy. The subjects enrolled had cre-atinine clearance values ranging from 95 to 150ml/min/1.75m2. At 8.00 a.m. blood samples were drawn from all the subjects for the evaluation of K+/Ca2+ flow induced by the Gardos effect [8] . Some of the blood was made unclottable by means of Na+ heparin; the remaining blood was washed three times with a physiological NaCl solution buffered with Tris-HC1, at pH 7.4; temperature was kept at 37 º C. The incubation medium for the erythrocytes was 107 mM NaCl and 20 mMTris-HC1 at pH 7.4, to which we added 0.2 mMof propranolol (final concentration), which gradually increased the intracellular Ca2+. To this solution we added 1 mM EGTA, which complexes Ca2+ and frees the medium of the Ca ions (0.2-1 mM), 3-iso-butylme-thylxantine (IBM-X 0.4 µM). Hematocrit of the erythrocyte suspension was set at 10% and measured with a cell counter (Sequoia Turner Cell Dyn 900). The osmolarity of the medium and of the suspension was checked by means of a Fiske Os Oximeter for a value of 290 mosm. Cells were first pre-incubated in the medium with propranolol alone for 30 min, then Ca (0.2 mM) was added whose presence generally determines a flux of K+ and therefore an influx of Ca2+ of about 20%. The cell volume was kept constant throughout the test period. The kinetic examination was made by taking a quantity of 0.5 ml every 5 min for 90 min. In healthy subjects, the K+ flow in the presence of 1 vaM Ca2+ was 20% at 30 min the values persisting until 90 min. The pattern in normotensive ADPKD subjects was analogous (28%). In the subjects with primary hypertension and in ADPKD subjects with hypertension, the K+ flow in the presence ofCa was < 55% from 30 min to 90 min and at all stages it was greater than in the normotensive subjects (p < 0.01, fig. 1 ). The presence of IBM-X, a phosphorodiesterase inhibitor, increased the K+ flow by 60% in healthy subjects and in normotensive subjects with ADPKD, while it did not affect the K7Ca2+ flow induced in subjects with primary hypertension in the ADPKD subjects with hypertension. Our results indicate that there is an anomaly in induced K+/Ca2+ transport in the erythrocytes of subjects with ADPKD and hypertension, which is identical to that found in subjects with primary hypertension [9] and might express a genetic membrane alteration. Although it has been suggested that renal cysts may give rise to hypertension independent of renal impairment [10] , we believe that a particular genetic order that can compromise the function of many systems of ionic transport may participate in the genesis of hypertension in subjects with ADPKD.
